Meanwhile, the S&P Sensex was down 123.40 points, or 0.41% at 29,850.84. The S&P BSE Small-cap index was down 57.25 points, or 0.39% at 14,727.43.

On the BSE, 2.81 lakh shares were traded on the counter so far as against the average daily volumes of 8.59 lakh shares in the past one quarter. The stock had hit a high of Rs 52.70 and a low of Rs 50.95 so far during the day.

The stock had hit a 52-week high of Rs 58.30 on 6 October 2016 and a 52-week low of Rs 36.95 on 1 February 2017. The stock had outperformed the market over the past one month till 5 April 2017, advancing 7.21% compared with the Sensex's 3.96% rise. The scrip had also outperformed the market over the past one quarter advancing 29.25% as against the Sensex's 11.52% rise.

The small-cap company has equity capital of Rs 40.93 crore. Face value per share is Rs 1.

Marksans Pharma had rallied 13.55% in the preceding four trading sessions to settle at Rs 52.80 yesterday, 5 April 2017, from its closing of Rs 46.50 on 29 March 2017.

Marksans Pharma's consolidated net profit fell 37% to Rs 11.30 crore on 1% decrease in net sales to Rs 215.24 crore in Q3 December 2016 over Q3 December 2015.

Marksans Pharma is a global pharmaceutical company. It is engaged in research & development (R&D) and offers CRAMS (contract research and manufacturing services) to global pharmaceutical companies.